Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

placebo

  • Open Access
    Adverse Events in Placebo Arms of Cancer Trials
    JOHANNES E. WOLFF, BIRTE J. WOLFF, MARCEAL M. THIELEN and HOLGER HAUCH
    Anticancer Research June 2022, 42 (6) 2805-2812; DOI: https://doi.org/10.21873/anticanres.15761
  • You have access
    Fatigue in Cancer Treatment Studies: Analysis of Placebo Arms
    HOLGER HAUCH, BIRTE J. WOLFF and JOHANNES E. WOLFF
    Anticancer Research January 2022, 42 (1) 45-52; DOI: https://doi.org/10.21873/anticanres.15455
  • You have access
    Anemia in Placebo Arms of Cancer Studies
    JOHANNES E. WOLFF
    Anticancer Research September 2021, 41 (9) 4543-4548; DOI: https://doi.org/10.21873/anticanres.15266
  • You have access
    Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
    BYOUNG CHUL CHO, TOMMASO DE PAS, HARALABOS KALOFONOS, QUN WANG, RODRYG RAMLAU, YING CHENG, FABIANA VITIELLO, TANEL LAISAAR, ERIC VALLIÈRES, BARTOSZ KUBISA, SERGEY ORLOV, KEUNCHIL PARK, CHANNA DEBRUYNE and JOHAN VANSTEENKISTE
    Anticancer Research March 2019, 39 (3) 1403-1409; DOI: https://doi.org/10.21873/anticanres.13255
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire